- Home
- The Road to a Vaccine
The Road to a Vaccine: How nurses are battling the COVID-19 pandemic
Season 1 of The Road to a Vaccine is an eight-episode educational video series that examines the latest efforts to respond to the COVID-19 pandemic and breaks down the complex process of developing a coronavirus vaccine.
Host Lisa Ling talks to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world who are working collaboratively to bring an end to the deadly pandemic.
In Episode 5, two nurses—one on the front lines in the ICU, and one leading the charge to advocate for her profession—talk about what caring for patients, and each other, really means right now. An activist talks about recovering from the virus and a scientist shares the challenges of creating a vaccine for clinical. Plus, Arianna Huffington and Husseini K. Manji, MD, FRCPC, discuss the other COVID-19 crisis: how it’s impacting mental health.
Note: This program originally aired on May 12, 2020.
Host Lisa Ling talks to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world who are working collaboratively to bring an end to the deadly pandemic.
In Episode 5, two nurses—one on the front lines in the ICU, and one leading the charge to advocate for her profession—talk about what caring for patients, and each other, really means right now. An activist talks about recovering from the virus and a scientist shares the challenges of creating a vaccine for clinical. Plus, Arianna Huffington and Husseini K. Manji, MD, FRCPC, discuss the other COVID-19 crisis: how it’s impacting mental health.
Note: This program originally aired on May 12, 2020.
Lisa Ling
Ling is the Executive Producer and host of This Is Life on CNN. She has also been a field correspondent for The Oprah Winfrey Show and a contributor to ABC News’ Nightline.
Macaya Douoguih, M.D., M.P.H.
Dr. Douoguih is Head of Clinical Development and Medical Affairs, Vaccines at the Janssen Pharmaceutical Companies of Johnson & Johnson. Dr. Douoguih heads a team of physicians and scientists that lead the clinical development of all viral and bacterial vaccine programs, including Ebola, RSV, HIV, E. coli and COVID-19 vaccines.
Michelle Elman
Elman is a 5-board accredited life coach, presenter and activist. She’s spoken at events for the Teenage Cancer Trust, Women’s Health Live and Stylist Live and has written for publications such as the Huffington Post, Metro, Stylist Magazine, the Daily Mail, Cosmo and Grazia. She is also the author of the book, “Am I Ugly?”.
Arianna Huffington
Huffington is the founder and CEO of Thrive Global, a leading behavior change tech company with the mission of changing the way we work and live. She’s also the founder of The Huffington Post, the author of 15 books including, most recently, “Thrive” and “The Sleep Revolution,” and has been named to Time Magazine’s list of the world’s 100 most influential people.
Nicole Lincoln MS, RN, FNP-BC, CCNS
Lincoln is a Critical Care Clinical Nurse Specialist and proud long-time bedside RN from Boston, Massachusetts. Her passion for nursing is deeply rooted in health equity, curiosity, innovation, caring and compassion. With 25 years of experience in critical care, education, innovation, quality improvement, nurse mentoring and leadership, she is looking forward to coaching the next generation of bright nurse leaders, innovators, scientists and entrepreneurs.
Husseini K. Manji, M.D., FRCPC
Johnson & Johnson’s Dr. Manji oversees all neuroscience programs investigating treatments for mood disorders, schizophrenia, and neurodegenerative diseases, such as Alzheimer’s disease. Previously, Dr. Manji was Chief of the Laboratory of Molecular Pathophysiology & Experimental Therapeutics at the National Institutes of Health (NIH).
She’s a scientist with one of the world’s most important jobs: Creating a potential COVID-19 vaccine
Imagine being a researcher who is staring down not only a highly infectious virus, but one that’s caused the first global pandemic in more than 100 years. Meet Johnson & Johnson’s Hanneke Schuitemaker, Ph.D.
